BIOLASE, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 7 rows in 2016. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2016-11-08: Reporting owner Flynn Harold C Jr.; Form 4/A; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2016-11-08: Reporting owner Flynn Harold C Jr.; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2016-08-25: Reporting owner Flynn Harold C Jr.; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2016-05-06: Reporting owner MOLL FREDERIC H; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2016-11-08 | Flynn Harold C Jr. Director, Officer (President and CEO) | 4/A | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,000,000 2,307,903 owned after | $1.45 exercise price | 2016-11-23 | |
| 2016-11-08 | Flynn Harold C Jr. Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,000,000 2,307,903 owned after | $1.45 exercise price | 2016-11-14 | |
| 2016-08-25 | Flynn Harold C Jr. Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +400,000 1,307,903 owned after | $1.44 exercise price | 2016-08-29 | |
| 2016-05-06 | MOLL FREDERIC H Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +120,152 350,989 owned after | $1.41 exercise price | 2016-05-11 | |
| 2016-05-06 | TALEVICH JAMES R Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +126,160 333,855 owned after | $1.41 exercise price | 2016-05-10 | |
| 2016-05-06 | CLARK PAUL N Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +231,293 550,876 owned after | $1.41 exercise price | 2016-05-10 | |
| 2016-05-06 | LORD JONATHAN T MD Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +120,152 293,739 owned after | $1.41 exercise price | 2016-05-10 |